Cargando…
1840. Implementation of a daptomycin dosing nomogram and assessment of clinical outcomes across a large health system
BACKGROUND: Daptomycin (DAP) is frequently used for a gram-positive infections with conflicting guidance on optimal dosing, especially dosing weight in obese patients. With newer commercially available vial sizes and limited supporting evidence pointing to an optimal dosing strategy and dosing weigh...
Autores principales: | Terravecchia, Ariana, Gopinathan, Vineet, Minor, Sarah B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752650/ http://dx.doi.org/10.1093/ofid/ofac492.1469 |
Ejemplares similares
-
1029. Clinical and economic outcomes of a newly implemented daptomycin dosing policy in a four-hospital health system
por: Todd, Meredith, et al.
Publicado: (2019) -
1084. Comparative Outcomes Among Patients Receiving Varying Daptomycin Dosing Regimens in Hemodialysis
por: Maxwell, Tyler, et al.
Publicado: (2021) -
759. High-Dose Daptomycin Is Well Tolerated via 2-Minute Infusion
por: Gill, Christian Mark, et al.
Publicado: (2019) -
1403. Daptomycin Combined with Low Dose Ceftriaxone Prevents the Emergence of Daptomycin Resistance against Streptococcus mitis-oralis Group in an In vitro Model of Simulated Endocardial Vegetations (SEVs)
por: Kebriaei, Razieh, et al.
Publicado: (2018) -
1546. Efficacy of Daptomycin Combinations Against Daptomycin-Resistant Enterococcus faecium Differs by β-lactam
por: Kebriaei, Razieh, et al.
Publicado: (2019)